Soma Pharmacy Blognews

Evotec takes over DeveloGen Evotec has acquired Germany-based DeveloGen, a biopharmaceutical company engaged in the discovery and development of new therapeutics for the treatment of metabolic and endocrine disorders with a particular focus on diabetes.

Theratechnologies appoints new president, CEO Theratechnologies, a Canadian biopharmaceutical company that discovers and develops therapeutic products, has appointed John-Michel Huss as president and CEO.

Pfizer to buy FoldRx Pharma Pfizer is set to acquire drug discovery and clinical development company FoldRx Pharmaceuticals under an agreement signed between the companies.

NIH funds Bionovo for female-specific obesity, metabolic syndrome drugs The US National Institutes of Health (NIH), National Center for Complementary and Alternative Medicine (NCCAM) Small Business Technology Transfer Program, has granted funds to Bionovo and Dale Leitman of University of California at Berkeley (UCB).

New antibacterial peptide effective against infections in burn or blast wounds An antibacterial peptide developed by Laszlo Otvos, a research professor of biology in Temple’s College of Science and Technology, looks to be a highly-effective therapy against infections in burn or blast wounds suffered by soldiers.

SaveRxCanada.com announces enhancement to online shopping system SaveRxCanada.com, the premier Canadian pharmacy intermediary since 2004, announced an enhancement to its full online shopping system.

Purdue University researchers develop new type of pump for drug-delivery patches Purdue University researchers have developed a new type of pump for drug-delivery patches that might use arrays of “microneedles” to deliver a wider range of medications than now possible with conventional patches.

iBio and CMB enter development and marketing collaboration with GE Healthcare iBio, Inc., its development collaborator, Fraunhofer USA Center for Molecular Biotechnology (CMB), and GE Healthcare, a unit of General Electric Company, today announced their entry into an agreement to jointly develop and globally market manufacturing solutions for biopharmaceuticals and vaccines based upon their respective [...]

Emergent BioSolutions signs contract with NIAID to develop third generation anthrax vaccine candidate Emergent BioSolutions Inc. announced today that it has signed a contract valued at up to $28.7 million with the National Institute of Allergy and Infectious Diseases, an institute within the National Institutes of Health, for advanced development of the company’s third generation [...]

AHF proposes innovative solution to resolve AIDS drug crisis in Florida As the State of Florida grapples with a budget shortfall that is crippling its AIDS Drug Assistance Program and forcing the state to place more than 1,300 low-income Floridians on waiting lists to access lifesaving AIDS medications, AIDS Healthcare Foundation has proposed an innovative [...]